DarioHealth Corp (DRIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DarioHealth Corp (DRIO) has a cash flow conversion efficiency ratio of -0.087x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.89 Million) by net assets ($67.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DarioHealth Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how DarioHealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DRIO total debt and obligations for a breakdown of total debt and financial obligations.
DarioHealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DarioHealth Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Electronic Certification Authority Inc
KQ:041460
|
0.036x |
|
Chia Her Industrial Co Ltd
TW:1449
|
-0.001x |
|
SKY LIGHT HOLDINGS LTD
F:27L
|
N/A |
|
Otto Holding AS
IS:OTTO
|
0.053x |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
0.070x |
|
Infrea AB
ST:INFREA
|
0.077x |
|
Bellavista Resources Ltd
AU:BVR
|
-0.067x |
|
Stars Microelectronics (Thailand) PCL
BK:SMT
|
0.044x |
Annual Cash Flow Conversion Efficiency for DarioHealth Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of DarioHealth Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see DarioHealth Corp (DRIO) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $67.92 Million | $-25.94 Million | -0.382x | +28.67% |
| 2024-12-31 | $72.02 Million | $-38.56 Million | -0.535x | -2.48% |
| 2023-12-31 | $58.14 Million | $-30.38 Million | -0.522x | +12.64% |
| 2022-12-31 | $80.00 Million | $-47.84 Million | -0.598x | -1.50% |
| 2021-12-31 | $85.55 Million | $-50.41 Million | -0.589x | +6.47% |
| 2020-12-31 | $28.15 Million | $-17.74 Million | -0.630x | +24.30% |
| 2019-12-31 | $18.89 Million | $-15.72 Million | -0.832x | +35.24% |
| 2018-12-31 | $8.93 Million | $-11.47 Million | -1.285x | +52.30% |
| 2017-12-31 | $3.94 Million | $-10.62 Million | -2.694x | -310.34% |
| 2016-12-31 | $-6.54 Million | $-8.38 Million | 1.281x | +115.86% |
| 2015-12-31 | $777.00K | $-6.28 Million | -8.079x | -338.94% |
| 2014-12-31 | $-2.54 Million | $-8.58 Million | 3.381x | -96.16% |
| 2013-12-31 | $-86.38K | $-7.60 Million | 87.979x | +3053.32% |
| 2012-12-31 | $-1.07 Million | $-2.98 Million | 2.790x | -- |
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to crea… Read more